Journal
FUTURE ONCOLOGY
Volume 8, Issue 1, Pages 37-54Publisher
FUTURE MEDICINE LTD
DOI: 10.2217/FON.11.131
Keywords
American Recovery and Reinvestment Act; comparative effectiveness research; cost-effectiveness; patient-centered outcomes research; prostate cancer; radiation therapy
Categories
Funding
- NCI Cancer Center [P30 CA56036]
Ask authors/readers for more resources
Comparative effectiveness research aims to help clinicians, patients and policymakers make informed treatment decisions under real-world conditions. Prostate cancer patients have multiple treatment options, including active surveillance, androgen deprivation therapy, surgery and multiple modalities of radiation therapy. Technological innovations in radiation therapy for prostate cancer have been rapidly adopted into clinical practice despite relatively limited evidence for effectiveness showing the benefit for one modality over another. Comparative effectiveness research has become an essential component of prostate cancer research to help define the benefits, risks and effectiveness of the different radiation therapy modalities currently in use for prostate cancer treatment.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available